MAPT and Alzheimer disease: Considering key AD pathogenic mechanisms, simultaneous interference with two or more causes associated with Aβ-induced tau hyperphosphorylation may achieve better therapeutic efficacy with multiple benefits by combining collaborative mechanisms.